指南与共识脊柱关节炎

英国风湿病学会银屑病关节炎生物制剂及靶向合成DMARDs治疗指南范围

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
指南 / 共识 · Rheumatology (Oxford) · 2021-01-01

该指南旨在更新成人银屑病关节炎(PsA)治疗的循证推荐,因2012年旧版发布后已有多种新 advanced therapy 获批。更新将针对PsA不同领域(关节炎、附着点炎、指趾炎、中轴病变和银屑病)及关键合并症,提供 advanced therapy 优化选择的实践指导,并更新治疗策略包括达标治疗(treat-to-target)方法。指南采用《Creating Clinical Guidelines: Our Protocol》所述方法和流程制定,该流程获NICE认证。

要点

  • 更新2012年BSR PsA指南,纳入新获批的 advanced therapy。
  • 按PsA不同领域及合并症指导 advanced therapy 选择。
  • 更新治疗策略,包括达标治疗(treat-to-target)方法。

核心结论

  • 该指南范围旨在为成人PsA患者提供更新的循证治疗推荐,涵盖 advanced therapy 的优化选择和治疗策略更新。

研究设计与样本

  • 指南采用《Creating Clinical Guidelines: Our Protocol》所述方法和流程制定,该流程获NICE认证。

关键数值与推荐

  • 推荐需考虑PsA不同领域(关节炎、附着点炎、指趾炎、中轴病变和银屑病)及关键合并症来优化选择 advanced therapy。
  • 治疗策略推荐包括使用达标治疗(treat-to-target)方法。

临床怎么用

  • 临床医生可依据该指南更新,针对PsA不同领域和合并症优化 advanced therapy 选择,并采用达标治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this guideline is to provide an update on evidence-based recommendations for treatment of adult patients with PsA. The previous BSR guidelines for PsA were published in 2012 and since that time, there have been many new advanced therapies licensed for PsA. This update will provide practical guidance for clinicians on the optimal selection of advanced therapies taking into account different domains of PsA (arthritis, enthesitis, dactylitis, axial disease and psoriasis) and key associated comorbidities. It will also update guidance on treatment strategy including the use of a treat-to-target approach. The guideline will be developed using the methods and processes outlined in Creating Clinical Guidelines: Our Protocol. (1) This development process to produce guidance, advice and recommendations for practice has National Institute for Health and Care Excellence (NICE) accreditation.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tillett W, Allen A, Tucker L, et al. Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Rheumatology (Oxford). 2021. PMID: 33097948. doi:10.1093/rheumatology/keaa526

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。